To evaluate the relative expression of FST and FSTL3 in ovarian cancer, we measured the concentrations of these proteins by ELISA in 96 ascites samples from 77 patients with various peritoneal tumors of ovarian cancer and other origins, both chemo-naïve and treated (Supplementary Material 2, Table S1). The gene discussed is FST; the disease is ovarian cancer.